Weide, Benjamin*; Pascolo, Steve†; Scheel, Birgit‡; Derhovanessian, Evelyna§; Pflugfelder, Annette*; Eigentler, Thomas K.*; Pawelec, Graham§; Hoerr, Ingmar‡; Rammensee, Hans-Georg†; Garbe, Claus*
*Department of Dermatology, Division of Dermatooncology
†Department of Immunology
§Department of Internal Medicine II, Section for Transplantation Immunology and Immunohaematology, University of Tübingen
‡CureVac GmbH, Tübingen, Germany
The work was funded by Deutsche Forschungsgemeinschaft grant SFB685.
Financial Disclosure: Hans-Georg Rammensee is a shareholder of CureVac GmbH. Ingmar Hoerr and Birgit Scheel are employees of CureVac GmbH. All other authors declare that there are no financial conflicts of interest in regards to this work.
Reprints: Benjamin Weide, Division of Dermatoy-oncology, Department of Dermatology, University of Tübingen, Liebermeisterstrasse 25, 72076 Tübingen, Germany (e-mail: [email protected]).
Received for publication December 24, 2008; accepted February 3, 2009
Benjamin Weide and Steve Pascolo contributed equally.